hotspot -WSS

hotspot

author：hotspot 2025-09-30 01:03:13 - browse：61697

NIH headquarters — NIH research fellows want to unionize, in large part because they want a raise. Will that mean less money for grants? Lydia Polimeni/NIH

Several thousand research fellows at the National Institutes of Health want to unionize, in large part because they want to raise their pay stipends to something resembling a living wage near the agency headquarters in Bethesda, Md. But with a Congress that is looking on in suspicion at the NIH’s research and a debt ceiling deal that limits budget increases, where is the money going to come from?

Unlike private companies, federal agencies can’t always just give raises. This varies widely across the government, and from position to position. NIH trainees actually have it better than most, because they aren’t subject to the rigid federal pay scale that governs how much most people working in the administration can make. That doesn’t mean, however, that there’s always money for raises. It’s Congress, not the NIH itself, that sets the agency’s budget.

Finding money for raises, therefore, necessarily means taking money from somewhere else, said Richard Freeman, a professor of economics at Harvard.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Lung cancer screening guidelines updated for cigarette smokers

entertainment

explore

WSS

How to convince healthy people to buy insurance

Inari Medical to buy amputation prevention company LimFlow

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Humans aren't the only ones with an imagination. Rats have it too

The Pandemic Treaty must support building strong health systems

focus

hotspot

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Woman returns to dialysis after doctors remove transplanted pig kidney

Drug repurposing or repositioning? The language matters

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Sports medicine is finally prioritizing gender equality

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Novavax promises a turnaround & Lilly roils the obesity market

All of Us, NIH's precision medicine initiative, gets a big boost

ChatGPT in medicine: STAT answers readers' burning questions

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

focus

FDA's Pazdur wants cancer trials to range beyond China alone

Gene therapy’s promise and the high cost of hope

Infant mortality in U.S. rose last year for first time in decades: CDC

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

NIH documents show early flaws of $1.6 billion long Covid program

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Wikipedia

entertainment

explore

focus